imiquimod has been researched along with Invasiveness, Neoplasm in 33 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (24.24) | 29.6817 |
2010's | 24 (72.73) | 24.3611 |
2020's | 1 (3.03) | 2.80 |
Authors | Studies |
---|---|
Carton, I; Henno, S; Lavoué, V; Lebreton, M; Levêque, J; Nyangoh-Timoh, K; Tesson, C | 1 |
Ariza, S; Espinosa, S; Naranjo, M | 1 |
Delman, KA; Farley, CR; Lopez-Aguiar, AG; Lowe, MC; Oh, G; Russell, MC | 1 |
Bulten, J; de Hullu, JA; Fons, G; Lok, CAR; Massuger, LFAG; Oonk, MHM; Slangen, BMF; van der Linden, M; van Doorn, HC; van Dorst, EBL; van Poelgeest, MIE | 1 |
Innamaa, A; Lippiatt, J; Melson, L; Mujukian, A | 1 |
DeWane, ME; Grant-Kels, JM; Kelsey, A; Oliviero, M; Rabinovitz, H | 1 |
Halpern, AC; Quigley, EA | 1 |
Bassukas, ID; Nakuçi, M | 1 |
Buttmann, N; Clad, A; Gieseking, F; Harter, P; Lellé, RJ; Luyten, A; Maass-Poppenhusen, K; Petry, KU; Sörgel, P | 1 |
Chen, FW; Egbert, BM; Kim, DD; Swetter, SM | 1 |
Karia, PS; Mora, AN; Nguyen, BM | 1 |
Galan, A; Higgins, HW; Lee, KC; Leffell, DJ | 1 |
Barrio, MM; Mordoh, J; Pizzurro, GA; Podhajcer, OL; Sganga, L; Tapia, IJ | 1 |
Burrall, BA; Christensen, SD; Fitzmaurice, SD; Fung, MA; Garcia, MS; Joo, J; King, B; Konia, T; Leventhal, J; Martinez, S; Maverakis, E; Monjazeb, AM; Patel, F; Shi, VY; Tran, K; Wilken, R | 1 |
Bartha, Á; Dirschka, T; Schmitz, L | 1 |
Fosko, SW; Missall, TA | 1 |
McCall, MW; Woodmansee, CS | 1 |
Busam, K; Marghoob, AA; Nadiminti, H; Nehal, KS; Scope, A | 1 |
Amon, LM; Chang, A; Disis, ML; Duan, H; Gad, E; Larson, ER; Lu, H; Tufvesson, H; Van Denend, N; Wagner, WM; Yang, Y | 1 |
Baek, GH; Cho, JH; Chung, MS; Gong, HS; Roh, YH | 1 |
Aaronson, NK; Blok, LJ; Ewing, PC; Gundy, CM; Heijmans-Antonissen, C; Helmerhorst, TJ; Quint, WG; Terlou, A; van Beurden, M; van Seters, M | 1 |
Botella-Estrada, R; Nagore, E | 1 |
Caminal, JM; Fabra, A; Ferreres, JR; Marcoval, J; Penín, RM; Piulats, JM | 1 |
Cruickshank, ME; Gurumurthy, M | 1 |
Guillén, C; Hilari, H; Llombart, B; Llorca, D; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillén, C; Traves, V; Villanueva, A | 1 |
Arentsen, HC; Cornel, EB; de Reijke, TM; Falke, J; Lammers, RJ; Pozzi, R; Ravic, M; Vergunst, H; Witjes, JA | 1 |
Moon, SD; Spencer, JM | 1 |
Fisher, GH; Lang, PG | 1 |
Hengge, UR; Schaller, J | 1 |
Cruces, M; de la Torre, C; Feal, C; Flórez, A | 1 |
Konstantopoulou, M; Lord, MG; Macfarlane, AW | 1 |
Chimenti, S; Fargnoli, MC; Lozzi, GP; Micantonio, T; Peris, K | 1 |
Li, LJ; Wagamon, K | 1 |
8 review(s) available for imiquimod and Invasiveness, Neoplasm
Article | Year |
---|---|
Paget's disease of the vulva: A challenge for the gynaecologist.
Topics: Administration, Topical; Antineoplastic Agents; Diagnosis, Differential; Female; Humans; Imiquimod; Lasers, Gas; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Photochemotherapy; Prognosis; Radiotherapy Dosage; Vulvar Neoplasms | 2021 |
Nonsurgical Therapies for Basal Cell Carcinoma: A Review.
Topics: Administration, Cutaneous; Aminoquinolines; Anilides; Antineoplastic Agents; Biphenyl Compounds; Carcinoma, Basal Cell; Clinical Trials as Topic; Fluorouracil; Humans; Imiquimod; Interferons; Meta-Analysis as Topic; Molecular Targeted Therapy; Neoplasm Invasiveness; Photochemotherapy; Pyridines; Randomized Controlled Trials as Topic; Risk Assessment; Skin Neoplasms | 2017 |
Melanoma on chronically sun-damaged skin: Lentigo maligna and desmoplastic melanoma.
Topics: B7-H1 Antigen; Biopsy; Dermatologic Surgical Procedures; Dermoscopy; Diagnosis, Differential; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Immunotherapy; Margins of Excision; Microscopy, Confocal; Mutation Rate; Neoplasm Invasiveness; Neurofibromin 1; Proto-Oncogene Proteins c-kit; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Skin; Skin Aging; Skin Neoplasms; Sunlight; Treatment Outcome | 2019 |
Microinvasive melanoma: cutaneous pharmacotherapeutic approaches.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Dicarboxylic Acids; Female; Fluorouracil; Geriatric Assessment; Humans; Imiquimod; Immunohistochemistry; Interferon-alpha; Male; Melanoma; Neoplasm Invasiveness; Pharmaceutical Preparations; Prognosis; Risk Assessment; Skin Neoplasms; Survival Analysis; Treatment Outcome | 2013 |
A quantitative systematic review of the efficacy of imiquimod monotherapy for lentigo maligna and an analysis of factors that affect tumor clearance.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Risk Assessment; Skin Neoplasms; Survival Rate; Treatment Outcome | 2015 |
Melanoma in situ: Part II. Histopathology, treatment, and clinical management.
Topics: Administration, Topical; Aminoquinolines; Biopsy, Needle; Carcinoma in Situ; Female; Humans; Imiquimod; Immunohistochemistry; Immunotherapy; Injections, Intralesional; Interferon-alpha; Laser Therapy; Male; Melanoma; Melanoma, Cutaneous Malignant; Mohs Surgery; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Skin Neoplasms; Treatment Outcome | 2015 |
[Imiquimod in the treatment of lentigo maligna].
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Contraindications; Cryotherapy; Disease Progression; Drug Approval; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanoma; Microscopy, Confocal; Mohs Surgery; Neoplasm Invasiveness; Skin Neoplasms; Treatment Outcome | 2011 |
Management of vaginal intraepithelial neoplasia.
Topics: Adult; Aged; Aminoquinolines; Antineoplastic Agents; Biological Products; Biopsy, Needle; Brachytherapy; Carcinoma in Situ; Female; Humans; Imiquimod; Immunohistochemistry; Laser Therapy; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Treatment Outcome; Ultrasonic Therapy; Vaginal Neoplasms | 2012 |
3 trial(s) available for imiquimod and Invasiveness, Neoplasm
Article | Year |
---|---|
Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial.
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Body Image; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Imiquimod; Middle Aged; Neoplasm Invasiveness; Quality of Life; Sexuality; Vulvar Neoplasms | 2011 |
Results of a phase 1 dose escalation study of intravesical TMX-101 in patients with nonmuscle invasive bladder cancer.
Topics: Administration, Intravesical; Adult; Age Factors; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Transitional Cell; Cystoscopy; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Imiquimod; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neoplasm Invasiveness; Neoplasm Staging; Netherlands; Patient Safety; Prospective Studies; Risk Assessment; Sex Factors; Survival Rate; Treatment Outcome; Urinary Bladder Neoplasms | 2013 |
Imiquimod 5% cream in the treatment of Bowen's disease and invasive squamous cell carcinoma.
Topics: Adjuvants, Immunologic; Aged; Aged, 80 and over; Aminoquinolines; Bowen's Disease; Carcinoma, Squamous Cell; Female; Humans; Imiquimod; Male; Neoplasm Invasiveness; Skin Neoplasms; Treatment Outcome | 2006 |
22 other study(ies) available for imiquimod and Invasiveness, Neoplasm
Article | Year |
---|---|
Recurrence Patterns after Primary Excision of Invasive Melanoma with Melanoma
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Male; Margins of Excision; Melanoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms | 2018 |
Vulvar Paget disease: A national retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Imiquimod; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Netherlands; Paget Disease, Extramammary; Retrospective Studies; Survival Rate; Vulvar Neoplasms; Vulvectomy | 2019 |
Extensive extramammary Paget's disease of the vulva involving the bladder postradical split skin graft reconstruction.
Topics: Aged, 80 and over; Antineoplastic Agents; Cystoscopy; Female; Gynecologic Surgical Procedures; Humans; Imiquimod; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Skin Transplantation; Urethral Neoplasms; Urinary Bladder Neoplasms; Vulvar Neoplasms | 2019 |
Office-based treatment of basal cell carcinoma with immunocryosurgery: feasibility and efficacy.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Ambulatory Care; Aminoquinolines; Carcinoma, Basal Cell; Cohort Studies; Cryosurgery; Feasibility Studies; Female; Follow-Up Studies; Greece; Humans; Imiquimod; Male; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Office Visits; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2013 |
Treatment of extramammary Paget disease of the vulva with imiquimod: a retrospective, multicenter study by the German Colposcopy Network.
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Analysis of Variance; Antineoplastic Agents; Cohort Studies; Colposcopy; Female; Follow-Up Studies; Germany; Humans; Imiquimod; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm Staging; Paget Disease, Extramammary; Retrospective Studies; Risk Assessment; Survival Rate; Treatment Outcome; Vulvar Neoplasms | 2014 |
Imiquimod 5% cream as primary or adjuvant therapy for melanoma in situ, lentigo maligna type.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Carcinoma in Situ; Chemotherapy, Adjuvant; Cohort Studies; Female; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Melanoma; Neoplasm Invasiveness; Neoplasm Staging; Retrospective Studies; Risk Assessment; Skin Cream; Skin Neoplasms; Survival Rate; Treatment Outcome | 2015 |
Cytokine-enhanced maturation and migration to the lymph nodes of a human dying melanoma cell-loaded dendritic cell vaccine.
Topics: Aminoquinolines; Animals; Cancer Vaccines; Cell Movement; Chemotaxis; Cytokines; Dendritic Cells; Humans; Imiquimod; Lymph Nodes; Matrix Metalloproteinase 9; Melanoma; Mice; Mice, Nude; Neoplasm Invasiveness; T-Lymphocytes | 2015 |
100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series.
Topics: Administration, Topical; Aminoquinolines; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imiquimod; Injections, Intralesional; Interleukin-2; Male; Melanoma; Melanoma, Cutaneous Malignant; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Staging; Retinoids; Retrospective Studies; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2015 |
Clinical and histological resolution of invasive squamous cell carcinoma by topical imiquimod 3.75%: a case report.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Imiquimod; Male; Neoplasm Invasiveness; Scalp; Skin Neoplasms | 2016 |
The use of imiquimod to minimize the surgical defect when excising invasive malignant melanoma surrounded by extensive melanoma in situ, lentiginous type.
Topics: Adjuvants, Immunologic; Aged, 80 and over; Aminoquinolines; Cheek; Female; Follow-Up Studies; Humans; Imiquimod; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Scalp; Skin Neoplasms; Wound Healing | 2009 |
Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Skin Neoplasms | 2009 |
Use of reflectance confocal microscopy to monitor response of lentigo maligna to nonsurgical treatment.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Cryosurgery; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Microscopy, Confocal; Middle Aged; Neoplasm Invasiveness; Skin Neoplasms; Treatment Outcome | 2010 |
Treatment failure of a TLR-7 agonist occurs due to self-regulation of acute inflammation and can be overcome by IL-10 blockade.
Topics: Acute Disease; Administration, Topical; Aminoquinolines; Animals; CD8-Positive T-Lymphocytes; Growth Inhibitors; Imiquimod; Inflammation Mediators; Interleukin-10; Ligands; Mammary Neoplasms, Experimental; Membrane Glycoproteins; Mice; Mice, Transgenic; Neoplasm Invasiveness; Random Allocation; Receptor, ErbB-2; Toll-Like Receptor 7; Treatment Failure; Up-Regulation | 2010 |
Bone invasion by squamous cell carcinoma in situ (Bowen's disease) of the finger during treatment with imiquimod 5% cream: case report.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Squamous Cell; Finger Joint; Fingers; Humans; Imiquimod; Magnetic Resonance Imaging; Male; Neoplasm Invasiveness; Radiography; Skin Neoplasms | 2010 |
[Descriptive analysis of cutaneous recurrence patterns in patients with melanoma].
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dacarbazine; Female; Humans; Imiquimod; Kaplan-Meier Estimate; Lymph Node Excision; Male; Melanoma; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Prognosis; Skin Neoplasms; Skin Ulcer | 2011 |
Conventional surgery compared with slow Mohs micrographic surgery in the treatment of lentigo maligna: a retrospective study of 62 cases.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Mohs Surgery; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasm, Residual; Paraffin Embedding; Reoperation; Retrospective Studies; Skin Neoplasms; Skin Pigmentation; Treatment Outcome | 2012 |
Clearance of invasive melanoma with topical imiquimod.
Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Female; Frail Elderly; Humans; Imiquimod; Inflammation; Melanoma; Neoplasm Invasiveness; Skin; Skin Neoplasms | 2013 |
Treatment of melanoma in situ on sun-damaged skin with topical 5% imiquimod cream complicated by the development of invasive disease.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Facial Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Melanoma; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Neoplasms, Radiation-Induced; Skin Neoplasms | 2003 |
Successful treatment of invasive squamous cell carcinoma using topical imiquimod.
Topics: Administration, Topical; Aged; Aminoquinolines; Biopsy, Needle; Carcinoma, Squamous Cell; Dose-Response Relationship, Drug; Drug Administration Schedule; Face; Follow-Up Studies; Humans; Imiquimod; Immunohistochemistry; Male; Neoplasm Invasiveness; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2004 |
Invasive squamous cell carcinoma treated with imiquimod 5% cream.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Humans; Imiquimod; Leg; Male; Neoplasm Invasiveness; Ointments; Skin Neoplasms; Treatment Outcome | 2004 |
Treatment of invasive squamous cell carcinoma with 5-percent imiquimod cream.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Drug Administration Schedule; Female; Humans; Imiquimod; Neoplasm Invasiveness; Ointments; Skin Neoplasms; Treatment Outcome | 2006 |
Recurrent invasive basal cell carcinoma after radiation and imiquimod: a case report.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Humans; Imiquimod; Male; Nasal Cavity; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Nose Neoplasms; Skin Neoplasms | 2007 |